Hui Peng

Hui Peng

Auto-generated profile, based on publicly available information

Hui Peng

Division of Molecular Genetics, Cancer and Stem Cell Research Program, Cancer Research Institute, Kanazawa University, Kakuma-machi, Kanazawa, Ishikawa, 920-1192, Japan

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 August 2023 in Cell
Verified
Journal Article
Open access
FTFei Tang
Fei Tang
JLJinhu Li
Jinhu Li
LQLu Qi
Lu Qi
DLDongfang Liu
Dongfang Liu
YBYufei Bo
Yufei Bo
ZZZemin Zhang
Zemin Zhang
Natural killer (NK) cells play indispensable roles in innate immune responses against tumor progression. To depict their phenotypic and functional diversities in the tumor microenvironment, we perform integrative single-cell RNA sequencing analyses on NK cells from 716 patients with cancer, covering 24 cancer types. We observed heterogeneity in NK cell composition in a tumor-type-specific manner. Notably, we have identified a group of tumor-associated NK cells that are enriched in tumors, show impaired anti-tumor functions, and are associated with unfavorable prognosis and resistance to immunotherapy. Specific myeloid cell subpopulations, in particular LAMP3+ dendritic cells, appear to mediate the regulation of NK cell anti-tumor immunity. Our study provides insights into NK-cell-based cancer immunity and highlights potential clinical utilities of NK cell subsets as therapeutic targets.

17 September 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
HSHao Song
Hao Song
JSJiaxi Song
Jiaxi Song
MCMing Cheng
Ming Cheng
MZMeijuan Zheng
Meijuan Zheng
TWTian Wang
Tian Wang
ZTZhi-gang Tian
Zhi-gang Tian
Natural killer (NK) cells exert critical roles in anti-tumor immunity but how their functions are regulated by epitranscriptional modification (e.g., N6-methyladenosine (m6A) methylation) is unclear. Here we report decreased expression of the m6A “writer” METTL3 in tumor-infiltrating NK cells, and a positive correlation between protein expression levels of METTL3 and effector molecules in NK cells. Deletion of Mettl3 in NK cells alters the homeostasis of NK cells and inhibits NK cell infiltration and function in the tumor microenvironment, leading to accelerated tumor development and shortened survival in mice. The gene encoding SHP-2 is m6A modified, and its protein expression is decreased in METTL3-deficient NK cells. Reduced SHP-2 activity renders NK cells hyporesponsive to IL-15, which is associated with suppressed activation of the AKT and MAPK signaling pathway in METTL3-deficient NK cells. These findings show that m6A methylation safeguards the homeostasis and tumor immunosurveillance function of NK cells.

1 February 2019 in Immunity
Verified
Journal Article
Closed access
JZJing Zhou
Jing Zhou
HPHui Peng
Hui Peng
KLKun Li
Kun Li
KQKun Qu
Kun Qu
BWBaohui Wang
Baohui Wang
ZTZhi-gang Tian
Zhi-gang Tian

26 March 2021 in Science
Verified
Journal Article
Closed access
PDF file
LBLu Bai
Lu Bai
MVMargaux Vienne
Margaux Vienne
LTLing Tang
Ling Tang
YKYann Kerdiles
Yann Kerdiles
MEMarion Etiennot
Marion Etiennot
ZTZhi-gang Tian
Zhi-gang Tian
An IFN-γ feedback loop: Innate lymphoid cells (ILCs) play important roles in tissue homeostasis and host defense. Type 1 ILCs (ILC1s) produce interferon-γ (IFN-γ) and require the transcriptional master regulator T-bet. The pathways underlying how these cells develop and differentiate have remained poorly understood. Bai et al. found that the adult mouse liver contains a population of Lin–Sca-1 + Mac-1 + hematopoietic stem cells (LSM HSCs) that preferentially differentiate into tissue-resident liver ILC1s. They further show that IFN-γ produced by mature ILC1s promotes the expansion and differentiation of LSM HSCs into ILC1s but not natural killer cells. This work expands our understanding of extramedullary hematopoiesis and underscores the unique immune status of the liver. Science , this issue p. eaba4177

1 June 2017 in Seminars in Immunology
Verified
Journal Article
Closed access
HPHui Peng
Hui Peng
ZTZhi-gang Tian
Zhi-gang Tian

1 February 2016 in Journal of Autoimmunity
Verified
Journal Article
Closed access
LTLing Tang
Ling Tang
HPHui Peng
Hui Peng
JZJing Zhou
Jing Zhou
YCYongyan Chen
Yongyan Chen
HWHaiming Wei
Haiming Wei
ZTZhi-gang Tian
Zhi-gang Tian